20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TEMSIROLIMUS, with a corresponding US DMF Number 24921.
Remarkably, this DMF maintains an Active status since its submission on May 28, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 10, 2014, and payment made on March 25, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II